Rora deficiency resulted in a more aggressive disease progression for B-ALL; whereas Rora over-expression diminished the pathogenicity of BCR/ABL1- induced B-ALL. This evidence concerns the gene BCR and precursor B-cell acute lymphoblastic leukemia.